After pricing controversy, EpiPen maker offers cheaper, generic version

Monday, August 29, 2016 - 09:31 in Mathematics & Economics

Ed AdamczykPITTSBURGH, Aug. 29 (UPI) -- Mylan N.V. announced a lower-cost generic version of the EpiPen after U.S. senators railed against the steep price increase to $500 last week.

Read the whole article on UPI

More from UPI

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net